Pharmaceutical executives are constantly looking for ways to cut down clinical development costs; listen to any pharma company’s earnings call for proof. And yet there are clinical development costs right in front of them that can be avoided.

from Forbes – Tech http://ift.tt/24BwRwi
via IFTTT